title: Interleukin-2 receptor antibody vs ATG for induction immunosuppression after liver transplantation: initial results of a prospective randomized trial.
authors.affiliation: Department of Surgery, Virchow Clinic, Free University, Berlin, Germany.
authors.forename: H P
authors.initials: HP
authors.lastname: Lemmens
authors.forename: J M
authors.initials: JM
authors.lastname: Langrehr
authors.forename: W O
authors.initials: WO
authors.lastname: Bechstein
authors.forename: G
authors.initials: G
authors.lastname: Blumhardt
authors.forename: H
authors.initials: H
authors.lastname: Keck
authors.forename: R
authors.initials: R
authors.lastname: Lüsebrink
authors.forename: M
authors.initials: M
authors.lastname: Knoop
authors.forename: R
authors.initials: R
authors.lastname: Lohmann
authors.forename: S
authors.initials: S
authors.lastname: Tullius
authors.forename: H
authors.initials: H
authors.lastname: Lobeck
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D000961:Antilymphocyte Serum / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006084:Graft Rejection / Q000453:epidemiology; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D016031:Liver Transplantation / Q000276:immunology* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000453:epidemiology; D011446:Prospective Studies; D015375:Receptors, Interleukin-2 / Q000276:immunology*; D015996:Survival Rate
chemical_list: D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum; D015375:Receptors, Interleukin-2; C079843:inolimomab